NCT03800693View on ClinicalTrials.gov

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 14, 2019

Primary Completion Date

September 17, 2025

Study Completion Date

September 17, 2026

Conditions
Malignant Digestive System Neoplasm
Interventions
DRUG

Fluorouracil

Given IV

DRUG

Leucovorin

Given IV

DRUG

Oxaliplatin

Given IV

Trial Locations (3)

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

30322

RECRUITING

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

RECRUITING

Emory Saint Joseph's Hospital, Atlanta

All Listed Sponsors
collaborator

Hematology/Oncology Pharmacy Association

UNKNOWN

collaborator

University of Pittsburgh

OTHER

lead

Emory University

OTHER